Marc Cerrada-Gimenez, PhD

Director of R&D Implementation

Location: Headquarters, Kuopio, Finland

Dr. Cerrada-Gimenez obtained his PhD in Biotechnology from the A.I. Virtanen Institute at the University of Eastern Finland in 2011. Shortly thereafter, Marc joined Charles River Discovery Services (Kuopio, Finland), where he led the Biomarker and in vitro team designing and leading multiple projects, which aimed at studying various neurodegenerative indications.

In 2016, he joined the biotech Minoryx Therapeutics as Head of Biomarker Discovery collaborating in the development of compounds for the treatment of rare diseases, with the most advanced candidate currently undergoing Phase II-III. During that time he acquired experience in the preparation and submission of regulatory documents for the EMA and FDA.

Contact directly

Marc Cerrada-Gimenez, PhD
Director of R&D Implementation